Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Relapse in Teenage and Young Adult (TYA) Patients Treated on a Pediatric Minimal Residual Disease (MRD) Stratified Protocol Is Associated with a Poor Outcome: Results from UKALL2003

Rob S Sellar, MBChB, FRCPath, Clare Rowntree, PhD, Ajay J. Vora, Caroline L Furness, MD, Nicholas Goulden, MD PhD, Chris Mitchell, FRCPCH, Anthony V. Moorman, PhD, Rachael Hough, MDBMBS,FRCP,FRCPath

Blood (2015) 126 (23): 2493.

https://doi.org/10.1182/blood.V126.23.2493.2493

Published: 2015

Journal Articles

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

Nadia L Amin, MBChB, MSc, MA, Sally Kinsey, MD FRCP, FRCPath, Richard Feltbower, PhD MSc, BSc, Ajay J. Vora, Nicholas Goulden, MD PhD, Rachel Wade, MSc, Chris Mitchell, FRCPCH, Rachael Hough, MDBMBS,FRCP,FRCPath, Clare Rowntree, PhD, Beki James, PhD MBChB, MA

Blood (2015) 126 (23): 2083.

https://doi.org/10.1182/blood.V126.23.2083.2083

Published: 2015

Journal Articles

No Evidence That PTEN Abnormalities Impact on Outcome in Pediatric Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated on the MRC UKALL2003 Trial

Sarah Jenkinson, MSc, Amy A Kirkwood, Nicholas Goulden, MD PhD, Ajay J. Vora, Chris Mitchell, Rachel Wade, Jeremy Hancock, Anthony V. Moorman, PhD, David C Linch, FMedSci, Rosemary E Gale

Blood (2014) 124 (21): 1077.

https://doi.org/10.1182/blood.V124.21.1077.1077

Published: 2014

Journal Articles

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Katharine Patrick, Rachel Wade, Nicholas Goulden, MD PhD, Chris Mitchell, Clare Rowntree, FRCPath, Jeremy Hancock, Rachael E Hough, MD, Ajay J. Vora, FRCPath

Blood (2014) 124 (21): 3702.

https://doi.org/10.1182/blood.V124.21.3702.3702

Published: 2014

Journal Articles

Barriers To Clinical Trial Enrolment For Teenagers and Young Adults With Acute Lymphoblastic Leukaemia: The Impact of Age Eligibility Criteria

Lorna Anne Fern, BSc, MSc, PhD, Clare Rowntree, PhD, Rachael E Hough, MD, Ajay J Vora, Adele Fielding, MB BS, PhD, Chris Mitchell, Nicholas Goulden, Robert Alston, PhD, Jillian Birch, MD, O'hara Catherine, PhD, Jeremy Whelan, MD FRCP

Blood (2013) 122 (21): 1401.

https://doi.org/10.1182/blood.V122.21.1401.1401

Published: 2013

Journal Articles

Excellent Outcome Of MRD Low Risk Patients Is Sustained With Greater Than 10 Years Follow Up – Results Of UK ALL Trials 1997 -2003

Jack Bartram, Rachel Clack, Rachel Wade, Ajay J Vora, Jeremy Hancock, Chris Mitchell, Sally Kinsey, Colin Steward, John P Moppett, MD, PhD, Nicholas Goulden

Blood (2013) 122 (21): 2635.

https://doi.org/10.1182/blood.V122.21.2635.2635

Published: 2013

Journal Articles

Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003

Katharine Patrick, FRCPath, Rachel Wade, Nicholas Goulden, Chris Mitchell, PhD, Clare Rowntree, FRCPath, Rachael E Hough, MD, Ajay J Vora

Blood (2013) 122 (21): 58.

https://doi.org/10.1182/blood.V122.21.58.58

Published: 2013

Journal Articles

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Clare Rowntree, PhD, Rachael E Hough, MD, Rachel Wade, Nicholas Goulden, Chris Mitchell, PhD, Ajay J Vora

Blood (2013) 122 (21): 57.

https://doi.org/10.1182/blood.V122.21.57.57

Published: 2013

Journal Articles

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Rachael E. Hough, MD, Clare Rowntree, Rachel Wade, Nicholas Goulden, Chris Mitchell, Ajay J. Vora

Blood (2013) 122 (21): 840.

https://doi.org/10.1182/blood.V122.21.840.840

Published: 2013

Journal Articles

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics

Anthony V. Moorman, PhD, Amir Enshaie, PhD, Lucy Chilton, Claire Schwab, BSc, Thelma Tembo, Sue Richards, PhD, Sally Kinsey, FRCPath, Ajay J Vora, FRCPath, Chris Mitchell, MD, PhD, Christine J Harrison, PhD, FRCPath

Blood (2012) 120 (21): 292.

https://doi.org/10.1182/blood.V120.21.292.292

Published: 2012

Journal Articles

Profile of Steroid Toxicity During Maintenance Treatment in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)

Jo Tomlins, RGN, BN, MSc, Samar Kulkarni, MD, MRCP, FRCPath, Clare Rowntree, Nicholas Goulden, FRCPath, Chris Mitchell, MD, PhD, Rachael Hough, FRCPath, Sue Richards, PhD, Rachel Clack, Adrian JC Bloor, PhD, FRCP, FRCPath, Ajay J Vora, FRCPath

Blood (2012) 120 (21): 4305.

https://doi.org/10.1182/blood.V120.21.4305.4305

Published: 2012

Journal Articles

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia

Ajay J. Vora, FRCPATH, Chris Mitchell, FRCPCH, Nicholas Goulden, FRCPATH, Sue Richards, DSc

Blood (2010) 116 (21): 496.

https://doi.org/10.1182/blood.V116.21.496.496

Published: 2010

Journal Articles

Selective Persistence of Distinct Stem/B Leukaemic Stem Cells In Childhood Acute Lymphoblastic Leukaemia In Clinical Remission.

Christoph Lutz, MD, Petter Woll, PhD, Anders Castor, MD, PhD, Helen Ferry, PhD, Christina Jensen, PhD, Joanne Green, Helene Dreau, Michael Lutteropp, Anna Schuh, MD, PhD, Georgina Hall, MD, PhD, Chris Mitchell, MD, PhD, Jan Zuna, MD, PhD, Veronica Buckle, PhD, Sten Eirik W Jacobsen, MD, PhD, Tariq Enver, PhD

Blood (2010) 116 (21): 1585.

https://doi.org/10.1182/blood.V116.21.1585.1585

Published: 2010

Journal Articles

Benefit of Targeted Intensification for NCI High Risk Childhood Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council Trial ALL97 and ALL97/99.

Ajay Vora, Rachel Ward, Jeanette Payne, Chris Mitchell, Tim Eden, Sally Kinsey, John Lilleyman, Sue Richards

Blood (2006) 108 (11): 1869.

https://doi.org/10.1182/blood.V108.11.1869.1869

Published: 2006

Journal Articles

Early Response to Induction Is Predictive of Survival in Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukaemia: Results of the Medical Research Council ALL 97 Trial.

Anindita Roy, MRCPCH, Mike Bradburn, MSc, Anthony V. Moorman, PhD, Julie Burrett, PhD, Chris Mitchell, FRCPCH, Sally E. Kinsey, FRCPath, Ajay J. Vora, FRCPath, John Lilleyman, FRCPath, Osborn Eden, FRCPath, Ian Hann, FRCPCH, Vaskar Saha, FRCPCH

Blood (2004) 104 (11): 165.

https://doi.org/10.1182/blood.V104.11.165.165

Published: 2004

NARROW

Relapse in Teenage and Young Adult (TYA) Patients Treated on a Pediatric Minimal Residual Disease (MRD) Stratified Protocol Is Associated with a Poor Outcome: Results from UKALL2003

Analysis of Long-Term Outcomes, Management and Prevalence of Osteonecrosis in UKALL 2003: 3.5% of Adolescents and Young Adults over 10 Years of Age with Acute Lymphoblastic Leukaemia Required Hip Replacement

No Evidence That PTEN Abnormalities Impact on Outcome in Pediatric Patients with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated on the MRC UKALL2003 Trial

Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial

Barriers To Clinical Trial Enrolment For Teenagers and Young Adults With Acute Lymphoblastic Leukaemia: The Impact of Age Eligibility Criteria

Excellent Outcome Of MRD Low Risk Patients Is Sustained With Greater Than 10 Years Follow Up – Results Of UK ALL Trials 1997 -2003

Characteristics and Outcome Of Children and Young Adults With Early T-Precusor (ETP) ALL Treated On UKALL 2003

Outcomes Of Teenagers and Young Adults On The UKALL 2003 Paediatric Trial For Children and Young People With Acute Lymphoblastic Leukaemia

Impact Of Age On Toxicity Associated With Chemotherapy For Acute Lymphoblastic Leukaemia (ALL): Results From The UK Prospective Study UKALL2003

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics

Profile of Steroid Toxicity During Maintenance Treatment in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)

UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia

Selective Persistence of Distinct Stem/B Leukaemic Stem Cells In Childhood Acute Lymphoblastic Leukaemia In Clinical Remission.

Benefit of Targeted Intensification for NCI High Risk Childhood Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council Trial ALL97 and ALL97/99.

Early Response to Induction Is Predictive of Survival in Childhood Philadelphia Chromosome Positive Acute Lymphoblastic Leukaemia: Results of the Medical Research Council ALL 97 Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only